Skip to Content
Merck
  • Clinicopathology of graft detachment after Descemet's membrane endothelial keratoplasty.

Clinicopathology of graft detachment after Descemet's membrane endothelial keratoplasty.

Acta ophthalmologica (2014-04-15)
Tobias Brockmann, Claudia Brockmann, Anna-Karina Maier, Jan Schroeter, Uwe Pleyer, Eckart Bertelmann, Antonia M Joussen, Necip Torun
ABSTRACT

To investigate pathomechanisms involved in graft detachment after Descemet's membrane endothelial keratoplasty (DMEK) and its clinical implications. In a prospective case series, 30 eyes with Fuchs' endothelial dystrophy underwent DMEK. Intraoperatively obtained recipients' endothelium-Descemet's membranes (EDMs) were investigated histologically and immunohistochemically. The postoperative donor graft status was categorized as attached or detached. Clinical and morphological parameters were analysed between the study groups. The detachment rate was 40% (12/30). There was no significant difference in postoperative visual acuity between the groups, but visual recovery was delayed in eyes with initially detached grafts. Gender, age, preoperative central corneal thickness or best corrected visual acuity did not influence the detachment rate. However, separation and disruption of the anterior banded layer (ABL) were frequently observed in patients with graft detachment, and ABL thickness was identified as a significant predictor for graft detachment. The ABL thickness was 2.5 ± 0.9 μm and 3.5 ± 1.6 μm in patients with attached and detached grafts, respectively. Immunohistologically, a deficiency of fibronectin and cytokeratin was observed within the ABL of patients with detached grafts. In contrast, a complete removal of the EDM with residual stromal collagen fragments was observed in patients with adherent grafts. Incomplete removal of the EDM, with residual ABL fragments on the recipients' corneal stroma, may be a risk factor for graft detachment after DMEK. The separation and disruption of the ABL might be promoted by a deficiency of matrix proteins, stronger biomechanical properties and a firm adherence to the posterior corneal stroma.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Fibronectin antibody, Mouse monoclonal, clone IST-4, purified from hybridoma cell culture
Sigma-Aldrich
Monoclonal Anti-COL1A1 antibody produced in mouse, clone 3G3, purified immunoglobulin, buffered aqueous solution